LIFE SCIENCES

Wilson Sonsini Goodrich & Rosati has developed a broad expertise in the field of life sciences. The firm's life sciences practice includes representation of more than 500 companies in biotechnology, biopharmaceuticals, drug discovery technology, genomics, medical devices, diagnostics, and health care services.

We regularly advise life sciences companies on both public and private equity and debt financings, mergers and acquisitions, research and development financings, and technology licensing and contracts, as well as day-to-day securities and corporate governance matters.

Since 1998, Wilson Sonsini Goodrich & Rosati has served as counsel to companies and investment banks in more than 50 public offerings involving life sciences companies, raising more than $7 billion. The life sciences attorneys maintain close ties with the venture capital funds most active in the space, and have represented more life sciences companies in the process of securing venture capital financing than any other law firm. Over the last five years, we have assisted our life sciences clients in raising more than $1.5 billion in VC financing.

We are also a leader in structuring and negotiating corporate alliances for a full range of business objectives. The firm has counseled more than 100 life sciences companies regarding the structure of major corporate collaborations.

To assist life sciences companies with the protection of their intellectual property, the firm maintains a dedicated team of intellectual property attorneys led by industry veterans with significant experience securing and defending patent positions. The firm runs a dedicated healthcare regulatory law practice to help life sciences clients successfully navigate complex regulatory mazes, secure timely approvals, and comply with strictly enforced regulatory laws in the U.S. and international markets.

The firm adapts its services to account for the varying conditions in the life sciences industry, such as longer product development timetables, regulatory and reimbursement issues, and unique relationships with the scientific and medical communities. Our team includes attorneys with advanced, technical, or scientific degrees and industry training to better serve the needs of our clients.